[INQ. NO. 2410E19] 815MnB Inc. is a healthcare company focused on treating neurodevelopmental disorders such as Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD).
815MnB is committed to improving the quality of life of children and addressing unmet treatment needs worldwide by developing noninvasive medical devices utilizing deep-tech technology. Through its global network, 815MnB expands accessibility and provides effective treatment options.
815MnB recently released its advanced non-invasive percutaneous vagus nerve stimulator called ‘KOCHILD tVNS,’ designed for children with Autism Spectrum Disorder (ASD). This wearable device has shown clinically proven effectiveness in improving social interaction and communication skills in the brain and alleviating behavioral problems – through micro-electrical stimulation.
KOCHILD improves symptoms in children by activating brain regions associated with mood regulation, communication, and social behavior, and this device is specifically designed for children aged 3 to 12 years.
KOCHILD tVNS is designed to provide noise-cancelling functionality and a safe stimulation- range, thus ensuring that children feel comfortable while using it.
KOCHILD tVN is a non-invasive treatment option that can be used in both home and clinical settings, and can be integrated into routine treatment procedures.

Providing an effective and innovative treatment option for managing autism spectrum disorders
KOCHILD tVNS provides families and healthcare providers with an effective and innovative treatment option for managing autism spectrum disorders, thereby helping to substantially improve children’s quality of life.
“Our latest product, KOCHILD tVNS, is easy for both parents and healthcare providers to apply, and so we expect to provide sustained symptom improvement through long-term use,” explained the company’s CEO.

 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods